Vertical: CNMBase Year: 2025
Market Size (2025)
$247.66M
Projected (2032)
$477.66M
CAGR (2022–2032)
9.9%
Key Players
10+
Market Overview
The Global Trichoderma Viride Market was valued at USD 247.66 Million in 2025 and is projected to reach USD 477.66 Million by 2032, expanding at a CAGR of 9.82% during the forecast period 2026–2032. Over 2025–2032 the market is expected to add USD 230.00 Million in absolute value, nearly doubling in size. Historically, the market grew from USD 186.15 Million in 2022 to USD 225.23 Million in 2024, reflecting the steady integration of Trichoderma-based biofungicides into integrated pest management (IPM), organic and natural farming programmes across major agricultural economies.
Trichoderma viride is a soil-inhabiting filamentous fungus used as a biological control agent against soil-borne and seed-borne plant pathogens such as Fusarium, Rhizoctonia, Pythium, Sclerotium and Macrophomina. Its commercial value rests on multiple modes of action, including mycoparasitism, competition for space and nutrients, the production of antifungal metabolites and cell-wall-degrading enzymes, and the induction of systemic resistance in host plants, together with documented plant-growth-promoting effects. These properties position T. viride products as both a crop protection input and a soil health input, giving them relevance across fruits and vegetables, cereals and grains, pulses, oilseeds, plantation crops and nurseries.
Key Findings
By Formulation, Wettable Powder was the largest segment in 2025 with a 45.0% share (USD 111.45 Million), while Liquid is the fastest-growing segment with a CAGR of 11.74% over 2026–2032.
By Crop Type, Fruits & Vegetables led the market in 2025 with a 50.0% share (USD 123.83 Million), while Cereals & Grains is the fastest-growing segment at a CAGR of 11.49%.
By Application Method, Soil Treatment accounted for the largest share of 45.0% in 2025 (USD 111.45 Million), whereas Seed Treatment is projected to grow the fastest at a CAGR of 12.20%.
By Region, Asia Pacific was the leading region in 2025 with a 40.0% share (USD 99.06 Million), and Middle East & Africa is the fastest-growing region with a CAGR of 11.39%.
At the country level, Brazil was the largest national market in 2025 at USD 39.92 Million, while Saudi Arabia is the fastest-growing country with a CAGR of 12.72% during 2026–2032.
Segmentation Summary
The market has been analysed by formulation (Wettable Powder, Liquid and Granules), crop type (Fruits & Vegetables, Cereals & Grains and Others), application method (Soil Treatment, Seed Treatment and Foliar) and region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis for 20 countries and country groups.
Wettable Powder remains the dominant formulation because of its low production cost, established manufacturing base and long history of registration, particularly in India and other Asian markets, where talc-based T. viride formulations are widely distributed. However, its share is projected to decline from 45.0% in 2025 to 40.1% in 2032 as Liquid formulations, which rise from 35.0% to 39.5%, gain traction on the back of easier handling, compatibility with drip irrigation and seed treatment equipment, and higher spore viability. Fruits & Vegetables generate half of total demand owing to high crop value and intensive disease pressure, while Cereals & Grains expand faster as seed treatment of field crops scales up. Soil Treatment is the principal mode of use, reflecting the organism's role as a rhizosphere colonist, while Seed Treatment records the highest growth as seed companies and growers adopt biological seed coatings.
Competitive Landscape Summary
The Global Trichoderma Viride Market is fragmented. Specialist T. viride producers are concentrated in India, where a large number of registered manufacturers supply wettable powder and liquid formulations through dealer networks and state agriculture department programmes. Prominent among these are IPL Biologicals, T. Stanes & Company, Multiplex Group and Kan Biosys. At the global level, biological crop protection groups such as Koppert, BioFirst Group (including BioWorks), Andermatt Group, Gowan Company (Isagro), Agrauxine by Lesaffre and UPL (through its NPP business) market Trichoderma-based biofungicides that compete directly with T. viride products for the same diseases, crops and distribution channels. Competition centres on strain efficacy, shelf life, registration breadth, price and access to growers. Since 2022, the industry has seen notable consolidation and capacity investment, including BioFirst's acquisitions of BioWorks and Biotrop in 2023, HAL Investments' EUR 140 million investment in Koppert in 2024, and IPL Biologicals' commissioning of a cGMP biologicals plant in Vadodara in 2026.
Challenges and Opportunities
The main challenges facing the market are limited shelf life and sensitivity of fungal spores to storage conditions, variability in field performance relative to chemical fungicides, quality inconsistency among small-scale producers, and lengthy and costly registration procedures in regulated markets such as the European Union. Price sensitivity among smallholder farmers and limited awareness of correct application practices also constrain adoption in developing markets.
Key opportunities include the development of liquid and advanced formulations with longer shelf life, the integration of T. viride into commercial seed treatment programmes for cereals, pulses and oilseeds, and expansion in high-growth geographies such as Latin America and the Middle East & Africa. Government initiatives supporting natural and organic farming, such as India's National Mission on Natural Farming launched in November 2024 and Brazil's bioinputs legal framework enacted in December 2024, are expected to widen the addressable grower base.
Future Outlook
The market is expected to sustain near-double-digit growth through 2032, supported by continued restrictions on synthetic fungicides, growth in residue-sensitive export horticulture, and the mainstreaming of biologicals within the portfolios of large crop protection companies. Asia Pacific will remain the largest regional market, adding USD 99.02 Million between 2025 and 2032, while Latin America will add USD 62.48 Million, led by Brazil. Product differentiation is likely to shift from basic talc-based powders towards liquid, granular and seed-applied formulations with verified strain identity, higher colony-forming-unit counts and longer shelf life, raising the importance of fermentation capacity, quality control and registration expertise as sources of competitive advantage.
The Trichoderma Viride Market market is projected to grow at a CAGR of 9.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Trichoderma viride Pers. is a filamentous, free-living ascomycete fungus (family Hypocreaceae) commonly found in soil, decaying wood and the rhizosphere of plants. Selected strains of T. viride are mass-produced through solid-state or liquid fermentation and formulated with carriers, nutrients and adjuvants to create biological fungicides and soil health products. Once applied to soil, seed, planting material or foliage, the fungus colonises the root zone and suppresses plant pathogens through mycoparasitism (coiling around and penetrating pathogen hyphae), secretion of hydrolytic enzymes such as chitinases and glucanases, production of antifungal secondary metabolites, competition for nutrients and infection sites, and induction of systemic resistance in the host plant. Many strains also enhance root growth and nutrient uptake.
For the purpose of this study, the Global Trichoderma Viride Market comprises the revenue generated from the sale of commercially formulated products in which Trichoderma viride is a declared active ingredient, used for the management of plant diseases and the improvement of plant and soil health in agriculture and horticulture. Market value is measured at the manufacturer level in USD Million.
Included in the scope:
Wettable powder, liquid (including liquid formulations and suspension concentrates) and granular formulations containing T. viride as a declared active ingredient, either alone or in combination with other microbial agents.
Products applied through soil treatment (including soil drenching, furrow application, nursery bed and drip application), seed treatment (including seed coating, seedling and set treatment) and foliar spraying.
Use across fruits and vegetables, cereals and grains, and other crops such as pulses, oilseeds, plantation crops, turf and ornamentals.
Excluded from the scope:
Industrial uses of Trichoderma species, including enzyme production (such as cellulases and xylanases for textile, pulp and paper, feed and biofuel applications).
Non-commercial, on-farm multiplication of Trichoderma cultures that is not sold as a formulated product.
Laboratory and research cultures, mother cultures and starter inoculum supplied for research purposes.
Scope of the Study
The study covers the global market for Trichoderma viride products and analyses it across the following dimensions:
By Formulation: Wettable Powder, Liquid, Granules
By Crop Type: Fruits & Vegetables, Cereals & Grains, Others
By Application Method: Soil Treatment, Seed Treatment, Foliar
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Timeline: historic years 2022–2024, base year 2025, forecast period 2026–2032
Currency and unit: USD Million
Research Objectives
To estimate the size of the Global Trichoderma Viride Market in value terms for the historic period 2022–2024 and the base year 2025, and to forecast it for 2026–2032.
To analyse the market by formulation, crop type and application method, and to identify the segments with the largest share and the highest growth potential.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges shaping the adoption of T. viride-based biofungicides.
To evaluate the regulatory frameworks governing the registration and use of microbial biocontrol agents in key regions.
To analyse the value chain, from strain selection and fermentation to distribution and end use, and the competitive forces operating in the industry.
To profile the competitive landscape, including the positioning of leading suppliers and key developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process designed to produce consistent and verifiable estimates of the Global Trichoderma Viride Market. The process comprised: (1) definition of the market, its segmentation and its geographic scope; (2) secondary research to build an understanding of the product, its applications, its regulatory status and its supplier base; (3) primary research with participants across the value chain to validate assumptions and gather qualitative insights; (4) market size estimation using top-down and bottom-up approaches; (5) data triangulation and validation; and (6) forecasting of the market over 2026–2032 on the basis of identified growth factors.
Secondary Research
Secondary research was used to collect information on the product, its uses, its regulatory status and the companies that supply it. The sources consulted were selected for their relevance to microbial crop protection and agricultural inputs and included:
Government and regulatory bodies: product registration databases and publications of the Central Insecticides Board & Registration Committee (India), the U.S. Environmental Protection Agency, the European Commission and the European Food Safety Authority, Health Canada's Pest Management Regulatory Agency, Brazil's Ministry of Agriculture and Livestock (MAPA) and other national authorities.
Public agricultural research institutions: publications of the Indian Council of Agricultural Research (ICAR) and its institutes, the USDA Agricultural Research Service, and national agricultural universities on the efficacy and recommended use of Trichoderma.
Industry associations: publications of biological crop protection associations such as the International Biocontrol Manufacturers Association (IBMA) and the Biological Products Industry Alliance (BPIA), and organic agriculture bodies such as FiBL and IFOAM – Organics International.
Company sources: annual reports, investor presentations, press releases, product labels and technical bulletins of manufacturers and distributors of Trichoderma-based products.
Trade and scientific literature: agricultural trade journals and peer-reviewed literature on biocontrol, plant pathology and formulation technology.
Paid and statistical databases: agricultural production and trade statistics, crop area data and company financial databases.
Primary Research
Primary research was conducted to validate the findings of secondary research, to fill data gaps and to obtain qualitative insights on market trends, pricing and competitive dynamics. In-depth interviews were carried out with participants on both the supply side and the demand side of the market.
Supply-side respondents: senior executives, product managers and technical and regulatory personnel at manufacturers of Trichoderma-based products, contract fermentation companies, formulators and distributors of biological crop inputs.
Demand-side respondents: commercial growers, farmer producer organisations, nursery operators, seed companies, agronomists, extension specialists and procurement personnel at agricultural input retailers and government agencies.
Objectives: to validate market size and segment splits, to understand product pricing and margins along the value chain, to assess adoption patterns by crop and application method, and to gauge expectations regarding regulatory changes and future demand.
Market Size Estimation
Market size was estimated using both top-down and bottom-up approaches, and the results were triangulated to arrive at the final estimates.
Top-down approach: the overall biofungicide and microbial biocontrol market was used as the starting point and narrowed to Trichoderma-based products and then to T. viride products, using share estimates by region derived from registration data, company information and expert inputs. The market was then split by formulation, crop type and application method.
Bottom-up approach: revenues of key manufacturers from Trichoderma viride products were estimated and aggregated at the country level, supplemented by estimates of the volume consumed (based on treated crop area and typical application rates) multiplied by average selling prices. Country estimates were aggregated into regional and global totals.
Data triangulation: the outputs of the two approaches were compared, discrepancies were investigated and reconciled through additional secondary research and expert interviews, and the final estimates were validated with industry participants.
Forecasting Methodology
Market forecasts for 2026–2032 were developed by projecting the base-year market forward on the basis of quantified and qualitative growth factors. The factors considered included growth in the area under organic and natural farming, regulatory restrictions on chemical fungicides, crop-wise disease incidence, the adoption of seed treatment and drip-based application, the introduction of new formulations, price trends, government subsidy and procurement programmes, and the investment plans of leading suppliers. Each segment and country was forecast individually, and the results were reconciled with regional and global totals. The forecasts were reviewed with industry experts to test their consistency with expected market developments.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032
Compound annual growth rate (CAGR) period: 2026–2032
Currency and unit: USD Million
Assumptions and Limitations
Market values are expressed in nominal US dollars at the manufacturer level; currency fluctuations are assumed to remain within historical ranges over the forecast period.
The regulatory environment for microbial biocontrol agents is assumed to remain supportive, with no major restrictions on the registration or sale of Trichoderma products in key markets.
Product revenues of privately held companies, which account for a large part of supply, are not publicly reported and have been estimated on the basis of secondary information and primary interviews.
Trichoderma products are frequently marketed as multi-strain or multi-microbe formulations; where T. viride is one of several declared active ingredients, the product has been included in the market.
Informal and unregistered products sold in some developing markets are difficult to quantify and may result in under-estimation of actual consumption in those countries.
Unforeseen events such as extreme weather, pandemics or trade disruptions could cause actual results to differ from the forecasts.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Trichoderma Viride Market is fragmented, with a large number of manufacturers and no single company holding a dominant position across regions. The supply base comprises two broad groups. The first consists of specialist T. viride producers, concentrated in India, where a large number of companies hold registrations for T. viride wettable powder and liquid formulations and compete through dealer networks, cooperatives and government procurement. The second consists of international biological crop protection companies that market Trichoderma-based biofungicides, often based on proprietary strains of Trichoderma harzianum, T. asperellum, T. atroviride or T. gamsii, which compete directly with T. viride products for the same diseases, crops and distribution channels in North America, Europe, Latin America and other regions.
Competition is based on strain efficacy and registration, product quality and shelf life, formulation technology, price, breadth of distribution and the technical support offered to growers. In India and other price-sensitive markets, competition among wettable powder producers is intense and frequently price-driven, including in government tenders. In regulated markets, the cost and duration of registration limit the number of competitors and favour companies with established regulatory capabilities. Since 2022, the industry has been shaped by consolidation and investment, as biological specialists and large crop protection companies expand their portfolios through acquisitions, licensing agreements and new production capacity.
Key Player Positioning
Leaders: Koppert and BioFirst Group are the leading international biological crop protection companies with Trichoderma-based biofungicides. Koppert, headquartered in the Netherlands, markets the Trianum range based on T. harzianum strain T-22 and has a very strong presence in Europe and Latin America, particularly Brazil. BioFirst Group (formerly Biobest Group), headquartered in Belgium, markets the RootShield and RootShield Plus ranges through BioWorks in the United States and has expanded into Brazil through Biotrop. Both companies combine broad product portfolios with global distribution and extensive experience in biological crop protection.
Challengers: Andermatt Group, Gowan Company (through Isagro), Agrauxine by Lesaffre, UPL and IPL Biologicals are positioned as challengers. Andermatt Group markets Trichoderma products such as T-77 and Atroverde 77 and has expanded through acquisitions in Europe, North America and South America. Gowan markets Remedier, a combination of T. asperellum and T. gamsii, and is extending its label uses. Agrauxine by Lesaffre develops proprietary Trichoderma strains and commercialises them through partners, including UPL, which launched the Atroforce seed treatment in the United States in 2025. IPL Biologicals is one of the leading producers of T. viride in India, marketing IPL Sanjeevni (T. viride 1.0% WP), and is expanding capacity and exports.
Niche players: T. Stanes & Company, Multiplex Group and Kan Biosys are established Indian suppliers of T. viride products with strong positions in specific states and crops. T. Stanes markets Biocure-F, based on T. viride, in wettable powder and liquid forms; Multiplex Group markets Multiplex Nisarga in wettable powder and liquid forms; and Kan Biosys markets Tricho-Shield Combat (T. viride 1.0% WP) and has formed a strategic alliance with France's DE SANGOSSE. In addition, a large number of small regional manufacturers supply T. viride products in India and other Asian markets.
Competitor Dashboard
The table below rates each profiled company on four parameters: the breadth of its Trichoderma and biological product portfolio, its regional presence, its strategic alliances, and its industry experience.
Threat of New Entrants: Medium
Production of basic wettable powder formulations requires relatively modest capital investment, and a large number of manufacturers hold registrations in markets such as India.
Barriers are higher in regulated markets, where registration of a new microbial strain requires substantial data, time and cost.
Established distribution networks, brand recognition and grower trust give incumbents an advantage over new entrants.
Bargaining Power of Suppliers: Low
Fermentation substrates, carriers such as talc and kaolin, and packaging materials are widely available commodities with many suppliers.
Most established manufacturers maintain their own strains and in-house fermentation, limiting dependence on external suppliers.
Supplier power is somewhat higher for proprietary strains licensed from research institutions or for specialised fermentation equipment.
Bargaining Power of Buyers: Medium
Smallholder farmers are price-sensitive and can choose among many competing products and chemical alternatives.
Large buyers such as government agriculture departments, distributors and seed companies negotiate on price through tenders and volume contracts.
Buyer power is lower for differentiated products with proven efficacy, strong registrations and agronomic support.
Threat of Substitutes: High
Chemical fungicides remain the primary substitute, offering faster and more predictable action at competitive prices.
Other biocontrol agents, including other Trichoderma species, Bacillus subtilis and Pseudomonas fluorescens, address similar diseases and compete for the same budget.
Cultural practices such as crop rotation, soil solarisation and resistant varieties can reduce the need for any treatment.
Competitive Rivalry: High
The market is fragmented, with many regional manufacturers and a smaller number of global biological crop protection companies.
Products are often perceived as similar, leading to price-based competition, particularly for wettable powders.
Rivalry is intensifying as large crop protection and biologicals groups expand their Trichoderma portfolios through acquisitions and licensing.
Threat of New Entrants: Medium; Low capital needs for basic formulations, offset by registration and distribution barriers.
Bargaining Power of Suppliers: Low; Commodity inputs and in-house strains and fermentation.
Bargaining Power of Buyers: Medium; Price-sensitive farmers and tender-based institutional buying.
Threat of Substitutes: High; Chemical fungicides and other biocontrol agents.
Competitive Rivalry: High; Fragmented supply base and price competition.
Market estimates by geography (2032)
InsightAsia Pacific leads with $198.09M by 2032, while Middle East & Africa is projected to grow fastest at a 11.0% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $28.76M | $43.98M | $66.63M | 8.8% | 14% |
| Europe | $29.04M | $43.68M | $64.96M | 8.4% | 14% |
| Asia Pacific | $73.06M | $120.94M | $198.09M | 10.5% | 41% |
| Latin America | $47.84M | $78.27M | $126.87M | 10.2% | 27% |
| Middle East & Africa | $7.45M | $12.33M | $21.11M | 11.0% | 4% |
| Total | $186.15M | $299.20M | $477.66M | 9.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$477.66M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Wettable Powder | $191.54M | 8.1% | 40% |
| Liquid | $188.91M | 11.9% | 40% |
| Granules | $97.20M | 10.2% | 20% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Trichoderma Viride Market covering market dynamics, competitive landscape, and strategic outlook.
The Trichoderma Viride Market market is projected to reach $477.66M by 2032, growing at 9.9% CAGR. The Wettable Powder segment holds the largest share.
The Global Trichoderma Viride Market is shaped by the convergence of regulatory, agronomic and commercial forces. Regulatory pressure on synthetic fungicides, the rising importance of residue-free produce in domestic and export markets, and government support for organic and natural farming are expanding the role of microbial biocontrol agents. At the same time, technical constraints related to shelf life and field consistency, along with registration costs and price sensitivity among farmers, temper the pace of adoption. This chapter assesses these factors. Table 4.1 presents the analysts' assessment of the key macro and micro factors influencing the market, with an impact score out of 10 assigned to each factor for three time periods. The scores are analyst assessments based on secondary research and industry interviews and indicate the relative strength of each factor's influence on market growth.
Regulatory Pressure on Synthetic Fungicides
Regulators in major agricultural markets have progressively restricted the use of synthetic fungicides and soil fumigants, creating demand for biological alternatives. In the European Union, active substances are reviewed under Regulation (EC) No 1107/2009, and several widely used fungicides have not been renewed in recent years; mancozeb, for example, was not renewed by Commission Implementing Regulation (EU) 2020/2087. The EU's Farm to Fork Strategy set a goal of reducing the use and risk of chemical pesticides by 50% by 2030. Although the proposed Sustainable Use Regulation intended to make this goal binding was rejected by the European Parliament in November 2023 and withdrawn by the Commission in February 2024, national action plans and retailer requirements continue to push growers towards lower-residue programmes. In parallel, the EU adopted dedicated data requirements and approval criteria for micro-organisms in 2022 (Regulations (EU) 2022/1438 and 2022/1439), intended to make the assessment of microbial active substances more suitable to their biology. In Asia, policies such as Japan's MIDORI Strategy for Sustainable Food Systems, which targets a 50% reduction in risk-weighted chemical pesticide use by 2050, point in the same direction. These measures enlarge the space for T. viride products in disease management programmes.
Expansion of Organic and Natural Farming
Growth in certified organic and chemical-free farming is a direct source of demand for T. viride, which is one of the most widely recommended biocontrol agents for organic disease management. According to FiBL and IFOAM – Organics International, the world's organic agricultural land reached 98.9 million hectares in 2024, managed by around 4.8 million producers, with global organic retail sales of approximately EUR 145 billion. India has the largest number of organic producers globally and one of the largest organic areas. Governments are actively supporting this transition: India launched the National Mission on Natural Farming in November 2024 with an outlay of INR 2,481 crore, targeting 7.5 lakh hectares and one crore farmers and planning 10,000 Bio-input Resource Centres to supply microbial inputs locally. Such programmes, together with the purchase of biocontrol agents by state agriculture departments for distribution to farmers, create a broad and recurring demand base for T. viride formulations, especially in wettable powder form.
Rising Burden of Soil-Borne Diseases and Fungicide Resistance
Soil-borne diseases such as damping-off, wilt, collar rot and root rot cause significant losses in vegetables, pulses, oilseeds, cotton, spices and plantation crops, and are difficult to control with foliar chemical fungicides. Intensive cropping, monoculture, protected cultivation and warmer, wetter weather associated with climate variability have increased the incidence of these diseases in many regions. At the same time, the development of resistance in pathogen populations to single-site fungicides has reduced the effectiveness of some chemical solutions. T. viride offers a preventive, root-zone solution that is compatible with IPM programmes and can be applied through seed, nursery, soil and drip routes. Public research and extension systems, including ICAR institutes and state agricultural universities in India, routinely recommend Trichoderma seed and soil treatment for a wide range of crops, which reinforces adoption among growers.
Investment and Consolidation in Agricultural Biologicals
Capital investment and consolidation in the biologicals industry are increasing the production capacity, registration capability and commercial reach available to Trichoderma products. Biobest (now BioFirst Group) completed the acquisition of BioWorks, maker of the RootShield Trichoderma range, in July 2023 and closed the acquisition of a majority stake in Brazil's Biotrop in December 2023 at an enterprise value of BRL 2.8 billion. Koppert received a EUR 140 million investment from HAL Investments in February 2024 to expand production. Andermatt Group has acquired majority stakes in biocontrol companies in Croatia, Canada and Argentina since 2022, and IPL Biologicals commissioned a cGMP-compliant biologicals plant in Vadodara, India, in May 2026. Large crop protection companies are also building biological portfolios; UPL launched the Trichoderma-based Atroforce seed treatment for U.S. cotton in January 2025. Such investments improve product availability, formulation quality and access to growers, supporting market expansion.
Liquid and Advanced Formulations
Liquid formulations are the fastest-growing formulation segment, projected to expand at a CAGR of 11.74% during 2026–2032. Liquid and oil-based formulations, encapsulated spores and improved granules offer longer shelf life, higher and more uniform spore concentrations, dust-free handling, and compatibility with drip irrigation, sprayers and seed treatment equipment. Suppliers that invest in fermentation technology and formulation science can command higher prices and access commercial growers and export-oriented horticulture producers that require consistent product performance.
Integration into Seed Treatment Programmes
Seed Treatment is the fastest-growing application method, with a CAGR of 12.20% over 2026–2032. Seed treatment uses small quantities of product per hectare, protects seedlings during the most vulnerable stage of growth and fits into the existing workflows of seed companies and treaters. Partnerships between biological suppliers and seed companies, together with the inclusion of biologicals in seed treatment packages alongside chemical fungicides and insecticides, offer an opportunity to scale T. viride use rapidly in cereals, pulses, oilseeds and cotton.
Expansion in High-Growth Emerging Markets
Middle East & Africa (CAGR 11.39%), Asia Pacific (CAGR 10.39%) and Latin America (CAGR 10.16%) offer above-average growth. Brazil's bioinputs sector has grown rapidly and gained a dedicated legal framework through Law No. 15,070 of December 2024. In the Middle East, investments in protected agriculture and food security programmes are creating demand for biological solutions suitable for controlled-environment production. Companies that establish local registrations, production partnerships and distribution networks in these regions are well positioned to capture growth.
Limited Shelf Life and Storage Sensitivity
As a living organism, T. viride loses viability over time, particularly when exposed to high temperatures, moisture and direct sunlight. Conventional talc-based powders typically have a shelf life of months rather than years, which complicates inventory management for distributors and retailers in hot climates and limits the ability of manufacturers to serve distant markets. Products that have lost viability before use deliver poor results, eroding grower confidence. Although improved formulations and packaging are addressing this constraint, shelf life remains a key barrier relative to chemical fungicides, which are stable for several years under ordinary storage conditions.
Variable Field Performance and Quality Inconsistency
The efficacy of T. viride depends on soil temperature, moisture, organic matter, pH and the native microbial community, so field results can vary more than those of chemical fungicides. The organism acts preventively and more slowly, which requires growers to change application timing and expectations. In addition, the fragmented supply base in several developing markets includes small producers with limited quality control, and products with colony-forming-unit counts below declared levels or with contamination have been reported in quality surveys of commercial biopesticides. Inconsistent quality undermines the reputation of the product category and slows adoption among commercial growers.
Registration Cost and Timelines in Regulated Markets
Registering a microbial active substance and its formulated products in regulated markets requires extensive data on identity, efficacy, toxicology and environmental fate. Industry participants report that registration of biopesticides in Europe can take six to ten years, compared with one to three years in many other markets. These costs and timelines are significant for the small and medium-sized companies that make up much of the Trichoderma industry, and they restrict the number of strains and products available in Europe and North America.
Challenge: On-Farm Production of Bioinputs
In some markets, growers produce microbial inputs on the farm for their own use. Brazil's bioinputs law of December 2024 allows farmers to produce bioinputs on-farm for their own use without product registration, provided they are not sold. On-farm multiplication can reduce demand for commercial formulated products and raises concerns about contamination and inconsistent quality. Commercial suppliers must therefore demonstrate clear advantages in strain quality, reliability and technical support.
Challenge: Price Competition and Commoditisation
In markets with a large number of registered manufacturers, such as India, T. viride wettable powders are widely available and frequently compete on price, including in government tenders. This compresses margins and limits investment in research and quality control. Suppliers need to differentiate through proprietary strains, higher spore counts, improved formulations and agronomic services to avoid commoditisation.
Trend: Multi-Strain Consortia and Combination with Biostimulants
Manufacturers are increasingly combining Trichoderma with other beneficial micro-organisms such as Bacillus, Pseudomonas and mycorrhizal fungi, or with biostimulants such as humic substances and seaweed extracts, to offer broader-spectrum products that address both disease suppression and plant vigour. Such products allow suppliers to differentiate in a crowded market and to position Trichoderma as part of soil health programmes rather than as a single-purpose fungicide.
Trend: Integration with Fertigation and Protected Cultivation
The growth of drip irrigation and protected cultivation is changing how T. viride is applied. Application through fertigation systems ensures delivery to the root zone, reduces labour and allows repeated applications through the cropping cycle. This trend favours liquid and fine-particle formulations and is particularly visible in greenhouse vegetables, berries and high-value horticulture in Europe, the Middle East, Mexico and parts of Asia.
The value chain of the Global Trichoderma Viride Market comprises four main stages, from the sourcing of strains and raw materials to the use of products by growers.
Value addition is concentrated in strain development, fermentation efficiency and formulation quality, which determine product efficacy and shelf life, and in distribution, where agronomic support and access to growers are critical. Margins at the distribution level are relatively high in fragmented markets because of the technical support required to drive adoption.
Trichoderma viride products are regulated as plant protection products or pesticides in most markets and must be registered before they can be sold. Key regulatory frameworks by region are summarised below.
The table below summarises key developments among leading companies in the market since 2022, including acquisitions, product launches, partnerships and expansions.
Sep 2022: Andermatt Group; Acquisition; Acquired an 80% stake in BIOinput d.o.o., a Croatian supplier of biological crop protection products.
Apr 2023: Kan Biosys; Partnership; Formed a strategic alliance with DE SANGOSSE (France), which invested in the company, to build a microbial biosolutions ecosystem in India.
May 2023: Andermatt Group; Product Launch; Andermatt Brasil launched Atroverde 77, a T. atroviride strain 77B biofungicide for white mould, in Brazil.
May 2023: IPL Biologicals; Partnership; Signed a joint venture agreement with Uzkimyosanoat (Uzbekistan) to manufacture and market biopesticides and biofungicides in Uzbekistan.
Jul 2023: BioFirst Group (Biobest); Acquisition; Completed the acquisition of BioWorks Inc. (United States), maker of the RootShield Trichoderma biofungicide range.
Dec 2023: BioFirst Group (Biobest); Acquisition; Completed the acquisition of a majority stake of around 85% in Biotrop (Brazil) at an enterprise value of BRL 2.8 billion.
Dec 2023: IPL Biologicals; Expansion; Signed a memorandum of understanding with the Government of Gujarat for an INR 400 crore biofertiliser and biopesticide manufacturing facility.
Feb 2024: Koppert; Investment; Received a EUR 140 million investment from HAL Investments to expand production facilities and support international growth.
Apr 2024: Koppert; Registration; The U.S. EPA accepted Triario WG and Triario P as alternate brand names for Trianum WG (T. harzianum T-22).
Apr 2024: BioFirst Group; Expansion; Adopted the BioFirst Group name and opened a EUR 12 million production facility in Westerlo, Belgium.
Jul 2024: Andermatt Group; Acquisition; Announced the acquisition of BioTEPP Inc. (Canada), a developer of biological crop protection products.
Oct 2024: Andermatt Group; Acquisition; Acquired an 80% stake in Agricheck Srl to expand its presence in Argentina and South America.
Jan 2025: UPL / Agrauxine by Lesaffre; Product Launch; UPL launched Atroforce, a T. atroviride K5 bionematicide seed treatment developed by Agrauxine, for U.S. cotton.
Sep 2025: BioFirst Group (BioWorks); Expansion; Launched the BioWorks biopesticide brand, including its Trichoderma products, on the European market.
May 2026: IPL Biologicals; Expansion; Commissioned an INR 200 crore cGMP-compliant biologicals manufacturing facility in Vadodara, Gujarat.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Trichoderma Viride Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
4 interactive charts drawn from the Trichoderma Viride Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Trichoderma Viride Market By Application Method
Global Trichoderma Viride Market By Crop Type
Global Trichoderma Viride Market By Formulation
Global Trichoderma Viride Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
